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a b s t r a c t
Glucagon-like peptide-1 (GLP-1) acts as a satiety signal andenhances insulin release. This study examined
how GLP-1 production from intestinal L-cells is modiﬁed by dietary changes.
Methods:Transgenicmousemodelswereutilized inwhich L-cells could bepuriﬁedby cell speciﬁc expres-
sion of a yellow ﬂuorescent protein, Venus. Mice were fed on chow or 60% high fat diet (HFD) for 2 or
16 weeks. L-cells were puriﬁed by ﬂow cytometry and analysed by microarray and quantitative RT-PCR.
Enteroendocrine cell populations were examined by FACS analysis, and GLP-1 secretion was assessed in
primary intestinal cultures.
Results: Two weeks HFD reduced the numbers of GLP-1 positive cells in the colon, and of GIP positive
cells in the small intestine. Puriﬁed small intestinal L-cells showed major shifts in their gene expres-
sion proﬁles. In mice on HFD for 16 weeks, signiﬁcant reductions were observed in the expression of
L-cell speciﬁc genes, including those encoding gut hormones (Gip, Cck, Sct, Nts), prohormone processing
enzymes (Pcsk1, Cpe), granins (Chgb, Scg2), nutrient sensing machinery (Slc5a1, Slc15a1, Abcc8, Gpr120)
and enteroendocrine-speciﬁc transcription factors (Etv1, Isl1, Mlxipl, Nkx2.2 and Rfx6). A correspond-
ing reduction in the GLP-1 secretory responsiveness to nutrient stimuli was observed in primary small
intestinal cultures.
Conclusion: Mice fed on HFD exhibited reduced expression in L-cells of many L-cell speciﬁc genes, sug-
gesting an impairment of enteroendocrine cell function. Our results suggest that a western style diet
may detrimentally affect the secretion of gut hormones and normal post-prandial signaling, which could
impact on insulin secretion and satiety.
Publis© 2015 The Authors.
. Introduction
Hormones from the gut control food intake and insulin release
s well as intestinal motility and secretion [1]. The post-prandial
ise in the plasma concentration of GLP-1 signals to the brain that
ood has arrived in the gastrointestinal tract and to the pancreas
hat glucose is being absorbed. GLP-1 brings about the sensation
f satiety together with the enhancement of insulin release [2]. As
ietary habits have changed and people now consumemore fat and
ugar, this raises concerns about whether dietary intake affects the
elease of gut hormones, and whether this in turn might contribute
o rising levels of obesity and diabetes.
∗ Corresponding authors..
E-mail addresses: fr222@cam.ac.uk (F. Reimann), fmg23@cam.ac.uk
F.M. Gribble).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.peptides.2015.06.006
196-9781/© 2015 The Authors. Published by Elsevier Inc. This is an open access article uhed by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
GLP-1, like other gut hormones, is released from enteroen-
docrine cells (EECs) located in the intestinal epithelium. EECs have
a life span of only about 5 days, and are constantly replenished from
stemcells in the intestinal crypts.Dependingon theirpositionalong
the gastrointestinal tract, EECs exhibit characteristic hormonal sig-
natures. In the duodenum, for example, there is a high number of
K-cells producing GIP, whereas in the distal ileum and colon there
are more L-cells expressing GLP-1 and PYY [3]. A few published
studies suggest that the number of EECs can be altered by environ-
mental stimuli. In intestinal organoid cultures in vitro, for example,
the number of L-cells is increased by exposure to short chain fatty
acids [4], and in vivo, elevated L-cell numbers have been observed
in germ-free mice [5], and in rodents on a high-ﬁber diet [6]. How
EECs are affected bydietary exposure is an area of great interest. If it
werepossible to increase L-cell number, this could lead to increased
GLP-1 release and improved glucose tolerance and satiety.
Surgical models have been used to investigate how EEC num-
bers are affected by exposure of different gut segments to luminal
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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utrients. In rats, gastric bypass surgery has been reported to result
n an increase in L-cell numbers in the roux (alimentary) and com-
on limbs [7,8]. In both cases, it was found that the increase in
-cell numbers was attributable to mucosal hypertrophy, but that
herewasno change in L-cell density. EECs alsodevelopednormally
n the biliopancreatic limb. These studies suggest that increased
leal nutrient exposure in the context of a chow diet results in
ucosal growth and a corresponding increase in L-cell number,
ut that the frequency of L-cells is not altered.
It is less clear how the intestine responds to diets containing a
igh fat content. In high-fat diet (HFD) fed rodents, it was reported
hat there is a reduction in the density of cells staining for chro-
ogranin A and GLP-1, and correspondingly reduced expression
f Gcg and Pyy by PCR [9,10]. In this study we have examined the
ranscriptomic and secretory properties of L-cells from mice fed on
high fat (60%), high sugar diet.
. Materials and methods
.1. Animals
All procedures were approved by the UK Home Ofﬁce and local
thical committee of the University of Cambridge.Male GLU-Venus
ice [11] on a C57Bl6 background were weighed at age 8 weeks
nd divided into 2 groups (n=4–6 per group), each with a balanced
ange of body weights. For the 16-week study, they were then sin-
le housed and placed on either a standard control chow (Special
iets Services, Rat and mouse breeder and grower diet) or high
at diet (Research Diets, #D12331, containing 60% energy from fat).
icewereweighedweekly for 16weeks.Mice on the 2-week study
ere treated similarly, butwerenot singlehoused.Micewerekilled
y cervical dislocation 2–4h after lights on. Intestinal tissues were
arvested and treated as below for ﬂow cytometry (FACS), mRNA
xtraction or secretion experiments.
.2. Small intestine for FACS sorting
For puriﬁcation of cell populations by FACS, intestinal pieces
ere stripped of the outer muscle layers. Tissue was chopped
nto 1–2mm pieces and digested to single cells with 1mg/ml
ollagenase in calcium-free Hanks Buffered Salt Solution (HBSS).
ingle cell suspensions were separated by ﬂow cytometry using
MoFlo Beckman Coulter Cytomation sorter (FL, USA). Side
catter, forward scatter and pulsewidth gateswere used to exclude
ebris and aggregates, and Venus positive cells collected at ∼95%
urity, alongside negative (control) cells that comprised a mixed
opulation dominated by other epithelial cell types.
.3. FACS analysis
Single cell suspensions were prepared for FACS analysis,
s described previously (9). Brieﬂy, cells were ﬁxed with 4%
araformaldehyde (PFA) in phosphate buffered saline (PBS), per-
eabilised with 0.1% (v/v) Triton X-100, blocked with 10% goat
erum and then incubated with primary antibody in PBS-10% goat
erum at 4 ◦C overnight for an hour at RT. The primary antibod-
es used were: anti-GIP (gifted by Prof. J.J. Holst; 1:1000), anti-CCK
gifted by Prof. G.J. Dockray; 1:500) and anti-PYY (Progen, London,
K; 16066; 1:100). Cells were rinsed 3 times and then incubated
ith secondary antibody (Alexa-Fluor 555, 633 or 647 Invitrogen,
SA; A-21435, A-21105, A-21428 or A-21070, all at 1:800). Cells
ere analysed using a LSRCyAn advance digital processing Flow
ytometer (Dako Cytomation, CA, USA; Fortessa (BD Biosciences)).
vents with very low side and forward scatter were excluded ass 77 (2016) 21–27
these are likely to represent debris, and events with a high pulse
width were excluded to eliminate cell aggregates.
2.4. RNA extraction and qRT-PCR
Tissues used for RNA and protein extraction were washed in
PBS and placed in RNAlater (Ambion, Life Technologies, Paisley,
UK) and frozen until processed. Samples were homogenized in
Tri-reagent (Sigma), and then treated as below. Total RNA from
FACS-sorted cells prepared from GLU-Venus transgenic mice was
isolated using amicro scale RNA isolation kit (Ambion). All samples
were reverse transcribed according to standard protocols. Quan-
titative RT-PCR was performed with 7900 HT Fast Real-Time PCR
system (Applied Biosystems, Life Technologies), using veriﬁed Taq-
man primer/probe sets supplied by Applied Biosystems. In all cases
expression was compared with that of -actin measured on the
same sample in parallel on the same plate, giving a CT difference
(CT) for -actin minus the test gene. Mean, standard error, and
statistics were performed on the CT data and only converted to
relative expression levels (2CT) for presentation in the ﬁgures.
2.5. Microarray
The quality of RNA samples was determined by Total RNA Pico
Chip (Agilent Technologies, Stockport, UK), and only thosewith RIN
values >7.0 selected for microarray analysis. Total RNA from the
sampleswere ampliﬁedusing theNuGENOvationPicoWTAsystem
(NuGEN Technologies, Leek, Netherlands) according to the man-
ufacturer’s protocol, labeled with the NuGEN Exon and EncoreTM
Biotin Modules, and hybridized onto Affymetrix Mouse Gene ST
1.0 arrays. Raw microarray image data were converted to CEL
ﬁles using Affymetrix GeneChip Operating Software. All the down-
stream analysis of the microarray data was performed using Gene-
SpringGX12.1 (Agilent). The CEL ﬁleswere used for both the robust
multi-array average (RMA) and Probe Logarithmic Intensity Error
(PLIER) analyses. After importing the data, each chip was normal-
ized to the 50th centile of the measurements taken from that chip.
To assess the purity of L-cell sorts, each probe on the microarray
datawasassignedavalue indicating its relativeexpression inL-cells
vs non-L-cells (combining all microarrays from HFD and chow-fed
mice), and the datawere ordered to indicate the top 50probesmost
enriched in thenon-L-cell population. ForeachL-cellmicroarraywe
then calculated the geometric mean of these 50 non-L-cell probes
as a measure of contamination by non-L-cells. One out of the 4
microarrays from HFD L-cells was excluded from further analysis
because its mean expression of non-L-cell probes was >2 SD above
the mean of all L-cell microarrays. In further analyses, the number
of individual microarrays used was: L-cells on chow (3), L-cells on
HFD (3), non-L-cells on chow (3) and non-L-cells on HFD (4).
2.6. Primary intestinal culture
Small intestinal and colonic primary cultures were prepared as
previously described [11]. Brieﬂy, mice 3–6 months old were sac-
riﬁced by cervical dislocation and the small intestine or colon was
excised. Luminal contents were ﬂushed thoroughly with PBS and
the outer muscle layer removed. Tissue was minced and digested
with Collagenase Type XI and the cell suspension plated onto 24-
well plates pre-coated with Matrigel (BD Bioscience, Oxford, UK).
2.7. GLP-1 secretion assay18–24h after plating, cells were washed and incubated with
test agents made up in 0.25ml saline buffer containing: (in mM:
138 NaCl, 4.5 KCl, 4.2 NaHCO3, 1.2 NaH2PO4, 2.6 CaCl2, 1.2 MgCl2,
and 10 HEPES, pH 7.4 with NaOH) supplemented with 0.1% BSA
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or 2h at 37 ◦C. At the end of the 2-h incubation, supernatants
ere collected and centrifuged at 2000 rcf for 5min and snap
rozen on dry ice. Cells were mechanically disrupted in 0.5ml
ysis buffer containing (mM): 50 Tris–HCl, 150 NaCl, 1% IGEPAL-CA
30, 0.5% deoxycholic acid (DCA) and complete EDTA-free protease
nhibitor cocktail (Roche, Burgess Hill, UK) to extract intracellular
eptides, centrifuged at 10,000 rcf for 10min and snap frozen. GLP-
was measured using an electrochemiluminescence total GLP-1
ssay (MesoScale Discovery, Gaithersburg, MD, USA) and results
xpressed as a percent of total (secreted+ lysate) GLP-1 and nor-
alized tobasal secretion in response to salinemeasured inparallel
n the sameday. Chemicalswerepurchased fromSigma (Poole, UK)
nless otherwise indicated.
.8. Data analysis
Results are expressed as mean± SEM. Statistical analysis was
erformed using GraphPad Prism 5.01 (San Diego, CA, USA). For
LP-1 secretion data, one-way ANOVA with post hoc Dunnett’s or
onferroni’s tests were performed on log-transformed secretion
ata, as these data were heteroscedastic. Values were regarded as
igniﬁcant when p<0.05.
. Results
.1. HFD affects the expression of gut hormone mRNAs in tissue
omogenates
Two weeks on HFD resulted in reduced expression of Gcg and
nsl5 in colonic tissue, and a tendency toward reduced expres-
ion of Cck and Pyy, suggesting that HFD causes either a reduction
n colonic L-cell density or impaired production of hormones by
ndividual enteroendocrine cells (Fig. 1). No signiﬁcant changes
ere observed in the expression of Gcg, Cck, Gip or Pyy in small
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ig. 1. Effect of 2 weeks HFD on hormone gene expression in the gastrointestinal tract. Ex
rom the small intestine (SI), colon and rectum of mice fed on chow (white bars) or HFD (
st (F) is shown relative to that of Actb measured in parallel on the same samples. Colum
epresent 1 SEM. Statistics were performed on the CT data (actb-gene of interest) and
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intestinal tissue homogenates, although we did detect an increase
in somatostatin (Sst)mRNA in the ileumof HFD-fedmice. Hormone
expression was unaffected in the rectum.
3.2. HFD alters gut peptide production by individual L-cells
To evaluate the frequency of L-cells and their individual pro-
duction of peptide hormones, we performed FACS analysis of
cell suspensions from transgenic mice expressing a yellow ﬂuo-
rescent protein Venus driven by the gcg promoter, which were
immunostained for different gut hormones. Quantiﬁcation of
Venus-labeled L-cells in different regions of the GI tract revealed
that the large intestine (colon+ rectum) of HFD-fed mice contained
a signiﬁcantly lower percentage of Venus positive L-cells than their
chow-fed littermates (Fig. 2A). In large intestinal cell suspensions
co-stainedwith antibodies against CCKandPYY,weobserved apar-
ticular reduction in the number of L-cells staining strongly for CCK,
and a corresponding increase in the intensity of L-cell PYY staining
in mice fed on HFD for 2 weeks (Fig. 2B–D).
In the upper small intestine, the frequency of Venus-labeled
L-cells was notmarkedly affected by the HFD (Fig. 2E). Both the fre-
quencyofGIP-stained cells (Fig. 2E), however, and theproportionof
L-cells that were immuno-positive for GIP (data not shown) were
reduced in small intestinal cell suspensions from HFD-fed mice.
Staining for PYY and CCK were not noticeably different between
the chow and HFD groups in the small intestine (Fig. 2E and data
not shown).
3.3. GLP-1 release is altered in intestinal cultures from HFD-fed
miceWenext evaluatedwhether the function of L-cellswasmodiﬁed
by high fat feeding. GLP-1 secretion was assessed in small intesti-
nal cultures from mice fed for 2 weeks on either HFD or chow
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pression of gut hormone mRNAs was quantiﬁed by qRT-PCR in tissue homogenates
black bars) for 2 weeks. Expression of Gcg (A), Gip (B), Cck (C), Pyy (D), Insl5 (E) and
ns represent the mean of n=5 (chow) and n=7 (HFD) samples, and the error bars
the data transformed by 2CT for illustration in the ﬁgures. *p<0.05, **p<0.01 by
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Fig. 2. Analysis of enteroendocrine cell numbers by FACS. (A) The frequency of L-
cellswas reduced in the colons ofmice fed onHFD for 2weeks (black bars) compared
with chow-fed controls (white bars), as assessed by counting Venus-positive cells
by FACS in tissues from GLU-Venus mice. (B–D) Colonic cell suspensions, as in (A),
were ﬁxed and stained for PYY and CCK, using red and far red secondary antibod-
ies. (B) The red/far red ﬂuorescence intensity histogram (indicating the intensity of
staining for PYY and CCK) of the Venus positive L-cell population is shown for one
representative each of a chow-fed (control) and HFD-fed mouse. Increased intensity
of PYY staining, and reduced intensity of CCK staining is apparent in the HFD-fed
mouse. (C) CCK and PYY staining obtained as in (B) are depicted for a representative
chow fedmousewithout/with primary antibodies (left and center, respectively) and
a HFD-fed mouse. Each dot represents an individual Venus-positive cell. (D) Mean
percentages of Venus-positive cells in quadrants 1–3 (Q1, Q2, Q3) for cell suspen-
sions analysed as in (C). (E) The small intestines of chow-fed andHFD-fedmicewere
analysed by FACS, as in (A, B), and the frequencies of cells positive for Venus, CCK
andGIPwere quantiﬁed as a percentage of the total cell number. Columns represent
the mean, and error bars represent 1 SEM of n=3 (colon) and n=5 (small intestine).
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hormone secretion, and reduced expression in L-cells of a numberp<0.05, ***p<0.001, by Student’s t-test.
Fig. 3). Cultures from chow-fed mice had a basal secretory rate
f 2.8% per 2h, which was stimulated 3.5-fold by 10mM glucose,
.9-fold by 0.5% peptone, 1.6-fold by 100M linoleic acid, 20-fold
y glucose/fsk/IBMX, 3.2-fold by 20mM Gly-Leu, and 5.6-fold by
MPMA. Cultures fromHFD-fedmice exhibited an increased rate
f basal GLP-1 release (5.0% per 2h, cf. 2.8% in chow-fed animals,
< 0.05). The ampliﬁcation of GLP-1 secretion above the basal rate
y glucose, peptone, forskolin/IBMX and Gly-Leu was reduced in
heHFD-fedgroup (Fig. 3) althoughabsolute% secretory rates in the
resence of different stimuli were similar in chow-fed andHFD-fed
ice.
Basal and stimulated GLP-1 release from colonic cultures wereot altered by placingmice onHFD for 2weeks (data not shown). In
ice fed for 16weeks onHFD, however, basal GLP-1 secretion from
olonic cultures was elevated ∼2-fold, from 2.4±0.2% per 2h ins 77 (2016) 21–27
chow fedmice (n=12wells fromn=4mice) to5.6±0.9% inHFD-fed
mice (n=9 wells from n=3 mice, p=0.0005).
3.4. Effect of HFD on L-cell gene expression
The effect of HFD on gene expression in L-cells was evaluated
using GLU-Venus mice that were fed on a HFD or chow diet for 16
weeks. HFD-feeding in this group resulted in a signiﬁcant increase
inbodyweight aswell as fat-padweight. Small intestinal L-cells and
non-L-cells from3 chow-fed and4HFD-fedmicewere separated by
FACS-sorting and subjected tomRNAmicroarray analysis. Intensity
values calculated by RMA analysis indicate the relative expression
of individual genes in L-cells and non-L-cells, and were compared
in both chow and HFD-fed cohorts (Fig. 4).
Gcg expression was not different between L-cells from HFD and
chow-fed mice. This was expected, as L-cells were collected based
on their ﬂuorescence of Venus driven by the gcg promoter. Expres-
sion of mRNAs for the gut hormones Gip, Cck, Pyy, secretin (Sct)
and neurotensin (Nts) were signiﬁcantly reduced in small intesti-
nal L-cells from HFD-fed mice (Fig. 4A). Corresponding with these
reduced mRNA levels for gut hormones, L-cells from HFD mice also
exhibited lower expressionof theprohormoneprocessing enzymes
Pcsk1 (prohormone convertase 1/3,p=0.026) andCpe (carboxypep-
tidase E, p=0.034) (Fig. 4B), aswell asmembers of the granin group,
particularly chromogranin B (Chgb, p=0.009) and secretogranin 2
(Scg2, p=0.019) (Fig. 4C).
To investigate whether the reduced ampliﬁcation of GLP-1
secretion by nutrients might correlate with lower expression of
nutrient-sensing machinery, we examined expression in L-cells of
candidate sensorymachinery for glucose (Slc5a1, Kcnj11, Abcc8 and
Gck), fatty acids (Gpr120, Ffar1), and oligopeptides (Slc15a1, Casr).
ExpressionofSlc5a1 (sglt1,p=0.017),Abcc8 (sur1,p=0.024),Slc15a1
(pept1, p=0.006) andGpr120 (p=0.017),were signiﬁcantly lower in
L-cells frommice onHFD than chow (Fig. 5A). The lower expression
of Slc5a1, Slc15a1 and Gpr120 in HFD L-cells was also conﬁrmed by
qRT-PCR (Fig. 5B).
To conﬁrm that the data do not represent a global reduction of
geneexpression inL-cells fromHFD-fedmice,weexaminedexpres-
sion of members of the fatty acid binding protein family. Fabp1, 2
and 6 were found to be ubiquitously expressed in the different gut
cell populations, whereas fabp5 expression was highly enriched in
L-cells (Fig. 4D). Expression of the non-L-cell enriched FABPs (1, 2
and 6) was high in both L-cells and non-L-cells and was unaffected
by HFD. Expression of Fabp5, by contrast, was enriched in L-cells
compared with control cells, and was signiﬁcantly lower in L-cells
from mice on HFD (p=0.01). Our data therefore suggest that feed-
ing mice with HFD results in reduced expression in L-cells of many
genes that determine the characteristics and function of an L-cell.
We further examined whether the down-regulation of L-cell
genes is accompanied by changes in expression of transcrip-
tion factors known to be involved in determination of the
enteroendocrine-cell lineage. As shown in Fig. 5C, L-cells from
mice on HFD exhibited a signiﬁcantly reduced expression of Etv1
(p=0.003), Isl1 (p=0.017), Mlxipl (p=0.009), Nkx2.2 (p=0.045) and
Rfx6 (p=0.009).
4. Discussion
Our data show that mice fed with a HFD exhibited changes
in their gut endocrine system compared with mice on chow diet.
There were small changes in enteroendocrine cell number, alteredof genes that determine the properties and function of an L-cell.
Examination of global gene expression in tissue homogenates
from different regions of the guts of mice fed for only 2 weeks on
P. Richards et al. / Peptides 77 (2016) 21–27 25
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Fig. 3. Effect of HFD on small intestinal GLP-1 release. Small intestinal cultures from mice fed for 2 weeks on chow (open bars) or HFD (black bars) were incubated for 2h in
control buffer (A), or in buffer containing 10mM glucose (Glc), 0.5% peptone (Pep), 100M linoleic acid (LA), 10mM glucose +10M forskolin +10M IBMX (F/I/G), 20mM
Gly-Leu (G-L) or 1M phorbol meryistate acetate (PMA) (B). GLP-1 concentrations were measured at the end of the experiment in both the supernatant and cell lysate of
each well. In (A), basal GLP-1 secretion is represented as the % of the total GLP-1 content released in 2h under control conditions (n=9 wells per column, comprising 3 wells
each from 3 independent mice). In (B), secretion has been normalized to the basal secretory rate measured in control wells from the same culture (n=9, as in (A)). *p<0.05,
***p<0.001 by 2-way ANOVA with post hoc Bonferroni test, performed on log transformed data.
Fig. 4. Effect of HFD on L-cell gene expression. Small intestinal L-cells and control non-L-cells were puriﬁed by FACS from mice fed for 16 weeks on chow or HFD, and
analysed using Affymetrix ST1.0 microarrays. Data are represented as the RMA intensity. Non-L-cells are represented by striped bars (chow, horizontal, n=3; HFD, diagonal,
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w=4), and L-cells by ﬁlled bars (chow, white, n=3; HFD, black, n=3). Expression of g
roteins (D) are illustrated. Data are depicted as the mean and 1SEM. Expression in
**p<0.001.
FD revealed changes in mRNAs for gut hormones, particularly in
he colon. The numbers of mice used for these experiments were,
owever, small and the data do not indicate whether the enteroen-
ocrine cell numberhas changed, orwhether the changes represent
lterations in hormonal expressionwithin EECs. FACS analysiswith
mmuno-staining was therefore performed to quantify EECs in dif-
erent regions of the gut and to conﬁrm the production of gut
ormones at the peptide level. This revealed that the number of
-cells was lower in the colons of HFD-fed mice, corresponding
ith the reductions in gene expression observed in the wholemones (A), prohormone processing enzymes (B), granins (C) and fatty acid binding
ls from chow and HFD mice was compared by Student’s t-test: *p<0.05, **p<0.01,
tissue homogenates. By FACS analysis it also appeared that the hor-
monal signature of colonic L-cells was shifted, with L-cells from
the fat-fed mice exhibiting reduced CCK production and a ten-
dency for increased PYY production. In the small intestine, by
contrast, L-cell numbers did not appear to be affected by high
fat feeding, but we observed a reduced number of GIP-stained
cells.As it has been reported that there are sufﬁcient L-cells in the
proximal small intestine to account for post-prandial hormone
release [12], we examined whether L-cell transcriptomics and
26 P. Richards et al. / Peptides 77 (2016) 21–27
Fig. 5. Effect of HFD on L-cell expression of nutrient sensing genes and transcription factors. Small intestinal L-cells and control non-L-cells were puriﬁed by FACS from mice
fed for 16 weeks on chow or HFD, and analysed using Affymetrix ST1.0 microarrays. Data in (A) and (C) are represented as the RMA intensity. Non-L-cells are represented by
striped bars (chow, horizontal, n=3; HFD, diagonal, n=4), and L-cells by ﬁlled bars (chow, white, n=3; HFD, black, n=3). (B) Gene expression in L-cells analysed by qRT-PCR,
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ormone release were altered in small intestinal L-cells. A large
umber of transcriptomic changes were observed in L-cells from
ice fed on HFD, with a signiﬁcant down regulation of expression
f mRNAs encoding L-cell speciﬁc transcription factors, enteroen-
ocrine hormones, prohormone processing enzymes, granins and
utrient sensing machinery. The data do not appear to represent
ither a global reduction in gene expression in L-cells, nor contam-
nationof the FACS-puriﬁedL-cell pool bynon-L-cells.We therefore
onclude that the L-cells in mice fed HFD had impaired production
f many genes required for the normal function of an enteroen-
ocrine cell. This coincided with reduced expression of a number
f EEC transcription factors. Isl1, Nkx2.2 and Rfx6 are transcription
actors well known to play a role in the EEC lineage [13–15]. As
fx6 has been reported previously to promote Gip expression [15],
he reduction in Rfx6 might account for our observation of reduced
ipmRNA in L-cells. Etv1 andMlxipl (encoding CHREBP) were iden-
iﬁed in our previous analysis of transcription factors enriched in
-cells [16]. The reduced expression in HFD L-cells of Slc5a1, Abcc8,
lc15a1 and Gpr120 would suggest that L-cells from mice on HFD
ight exhibit reduced nutrient responsiveness [17–19]. Indeed
he changes in gene expression corresponded with an apparent
educed responsiveness of GLP-1 release to L-cell secretagogues
n primary small intestinal cultures. Basal GLP-1 release, by con-
rast was elevated both in small intestinal cultures of mice fed with
FD for 2 weeks, and in colonic cultures of mice fed on HFD for
months. It is unclear why the basal rate of GLP-1 release wasncreased in the HFD-fed models, but we have observed a simi-
ar ﬁnding in ob/ob mice fed on chow (AMH, FG, FR unpublished
bservations). Whilst we cannot exclude the possibility that the L-
ells from HFD and ob/ob mice are more fragile, resulting in thew, white, n=4; HFD, black, n=4. In all panels, expression in L-cells from chow and
lysis of a few cells during the incubation period that would mimic
a high basal secretory rate, we believe it is more likely that an
imbalance of second messenger signaling pathways underlies this
increased rate of basal secretion in the absence of added nutritional
stimuli.
Our data showed that substantial changes in the properties of
L-cells arose when mice were fed on a HFD. Compared with chow,
the HFD we used contained a higher percentage of fat (60%) and
free sugars, and no ﬁber. We cannot therefore be certain which of
these dietary macronutrient changes was responsible for the alter-
ations in L-cell gene expression. Diets rich in fat and sugar and low
in ﬁber are, however, commonly consumed by humans in thewest-
ernworld.Ourdatawould suggest that suchdietsmayhaveadverse
effects on our gut hormones. Whether humans who eat a diet rich
in fat and sugar for prolonged periods exhibit increased basal GLP-1
release and lowered responsiveness to food ingestion will be inter-
esting to examine in the future. A reduced post-prandial elevation
of GLP-1 would, however, tend to lower the body’s ability to signal
satiety, and could result in a vicious cycle of over-eating. Resetting
gut hormone responsiveness by a period on a healthy diet might,
therefore be a strategy to increase post-prandial satiety and tackle
obesity.
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